Nuversys
PrivateLast Round
Series A
Mar 17, 2024
Est. Valuation
$9.5M
Total Funding Raised
$5.04M
Company Overview
Nuversys is a food-tech company that offers patented, nutrient-dense food ingredients based on a proprietary microencapsulation technology.
Sector
Healthcare & Life Sciences
Verticals
Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuversys Comparables
Compare Nuversys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TasteTech | 75% | |
| ADAMA Ltd. | 69% | |
| Balchem Corporation | 68% | |
Nuversys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 17, 2024 | ||||
| Convertible Debt | Sep 10, 2023 | ||||
| Seed | Mar 3, 2021 |
Nuversys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FEAT Investments | Series A, Convertible Debt, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2024
$1.5M round led by FEAT Investments
- Sep 10, 2023
$940K round led by FEAT Investments
Nuversys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuversys's valuation, stock price, and market status.